Lung Cancer Screening Prevalence and Changes in 2024
-
By
-
Todd Burus
-
Caree R. McAfee
-
Jennifer Redmond Knight
-
Timothy W. Mullett
-
Pamela C. Hull
-
June 1, 2026
-
Objective:
To compare up-to-date (UTD) lung cancer screening prevalence in 2024 across various groups and states and to assess changes since 2022.
Key Findings:
- 24.49% of eligible respondents were UTD on their screenings in 2024.
- UTD prevalence increased by 6.00 percentage points since 2022.
- Significant increases in UTD prevalence were observed across most subgroups, except for uninsured individuals and certain ethnic groups.
Interpretation:
Remove this section.
Limitations:
- Biases inherent to self-reported data.
- Exclusion of adults aged 80 years in temporal analysis.
- Differences in survey design and administration may affect results.
Conclusion:
Revise to eliminate unsupported claims and focus on findings.
